Graham Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-379,900
| Closed | -$6.81M | – | 1598 |
|
|
2025
Q1 | $6.81M | Buy |
379,900
+362,285
| +2,057% | +$6.49M | 0.12% | 77 |
|
|
2024
Q4 | $307K | Buy |
+17,615
| New | +$307K | ﹤0.01% | 893 |
|
|
2023
Q4 | – | Sell |
-16,071
| Closed | -$144K | – | 1331 |
|
|
2023
Q3 | $144K | Sell |
16,071
-19,287
| -55% | -$172K | ﹤0.01% | 891 |
|
|
2023
Q2 | $543K | Buy |
+35,358
| New | +$543K | 0.02% | 523 |
|
|
2022
Q1 | – | Sell |
-7,791
| Closed | -$241K | – | 1014 |
|
|
2021
Q4 | $241K | Buy |
+7,791
| New | +$241K | 0.01% | 388 |
|